Merck (MRK) said today it has formed a joint venture with Indias Sun Pharmaceutical Industries to develop, manufacture and commercialize new combinations and formulations of branded generics in emerging markets. Merck said the partnership combines Sun Pharmas track record of leadership and expertise in rapid and innovative product development with Mercks clinical development and registration expertise.